How Do We Interpret the Presence of Donor-Specific Antibodies When There Is No Rejection?

por Crew, R. John, Fajardo, Melissa
Publicado 2019

Understanding the Risks of Immunosuppression Reduction for Active COVID-19 Infection

por Meena, Priti, Crew, R. John
Publicado 2022

Imagining a Better Outcome for Chronic Antibody-Mediated Rejection—Will Blocking Interleukin-6 Signaling Help?

por Muthukumar, Thangamani, Crew, R. John
Publicado 2022

Association Between Donor-Recipient Biological Relationship and Allograft Outcomes After Living Donor Kidney Transplant

por Husain, S. Ali, King, Kristen L., Sanichar, Navin, Crew, R. John, Schold, Jesse D., Mohan, Sumit
Publicado 2021

Postvaccine Anti–SARS-CoV-2 Spike Protein Antibody Development in Kidney Transplant Recipients

por Husain, Syed Ali, Tsapepas, Demetra, Paget, Kathryn F., Chang, Jae-Hyung, Crew, R. John, Dube, Geoffrey K., Fernandez, Hilda E., Morris, Heather K., Mohan, Sumit, Cohen, David J.
Publicado 2021

Impact of Deceased Donor Kidney Procurement Biopsy Technique on Histologic Accuracy

por Husain, S. Ali, Shah, Vaqar, Alvarado Verduzco, Hector, King, Kristen L., Brennan, Corey, Batal, Ibrahim, Coley, Shana M., Hall, Isaac E., Stokes, M. Barry, Dube, Geoffrey K., Crew, R. John, Perotte, Adler, Natarajan, Karthik, Carpenter, Dustin, Sandoval, P. Rodrigo, Santoriello, Dominick, D’Agati, Vivette, Cohen, David J., Ratner, Lloyd, Markowitz, Glen, Mohan, Sumit
Publicado 2020